Abstract: Inherited mutations in the Krebs cycle enzyme fumarate hydratase (FH) predispose to hereditary leiomyomatosis and renal cell cancer (HLRCC). Loss of FH activity in HLRCC tumours causes accumulation of the Krebs cycle intermediate fumarate to high levels, which may act as an oncometabolite through various, but not necessarily mutually exclusive, mechanisms. One such mechanism, succination, is an irreversible non-enzymatic modification of cysteine residues by fumarate, to form S-(2-succino)cysteine (2SC). Previous studies have demonstrated that succination of proteins including glyceraldehyde 3-phosphate dehydrogenase (GAPDH), kelch-like ECH-associated protein 1 (KEAP1) and mitochondrial aconitase (ACO2) can have profound effects on cellular metabolism. Furthermore, immunostaining for 2SC is a sensitive and specific biomarker for HLRCC tumours. Here, we performed a proteomic screen on an FH-mutant tumour and
Introduction
The accumulation of metabolites resulting from cancer-associated mutations in genes encoding key metabolic enzymes has been proposed to drive oncogenic transformation [1] . Mutations in genes encoding isocitrate dehydrogenase 1 and 2 (IDH1/2), succinate dehydrogenase (SDH) and fumarate hydratase (FH) can lead to high intracellular levels of D-2-hydroxyglutarate (D2HG), succinate and fumarate, respectively [2] . Due to their structural similarity to 2-oxoglutarate (2OG), these oncometabolites have been demonstrated to modulate the activities of 2OG-dependent dioxygenases; a family of enzymes with diverse functions including epigenetic regulation, oxygen sensing, collagen maturation and regulation of translation [3] [4] [5] [6] [7] [8] . Fumarate is an electrophile that reacts with cysteine residues in susceptible proteins to form S-(2-succino)cysteine (2SC), a biomarker of mitochondrial stress in obesity and diabetes, and of FH-deficiency in hereditary leiomyomatosis and renal cell cancer (HLRCC) patients [9] [10] [11] [12] . Succination is a non-enzymatic and irreversible reaction, which seems to preferentially target cysteine residues with low pKa values [13] , although other factors affecting the susceptibility to succination may exist. To date, several studies have detected succinated proteins in a variety of animal and cellular models and have identified functional consequences associated with a range of cellular responses including activation of the Nuclear factor (erythroid-derived 2)-like 2 (NRF2)-mediated antioxidant pathway, inhibition of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and mitochondrial aconitase (ACO2) activity, and amplification of reactive oxygen species (ROS) signaling [13] [14] [15] [16] . Here, we performed a proteomic-based screen using tandem mass spectrometry (MS/MS) to analyse an FH-deficient tumour and two FH-mutant cell lines derived from metastatic renal cancers. We identified 60 succinated proteins, 10 of which were modified at cysteine residues either predicted or experimentally proven to be functionally important. This study has expanded our knowledge of the succinated proteome in FH-associated renal cancer and identified novel 2SC targets, which may contribute to HLRCC tumourigenesis.
Results and Discussion

HLRCC Tumours and Derived Cell Lines Exhibit High Levels of 2SC
In order to verify the presence of succinated proteins in the FH-mutant tumour-derived cell lines UOK262 [17] and NCC-FH-1 (unpublished cell line kindly provided by Prof. Bin Teh), we performed immunoblotting using an anti-2SC antibody [18] . Strong immunoreactivity for 2SC was observed in both of these HLRCC cell lines but was absent in a normal renal proximal tubular epithelial cell line (RPTC) [19, 20] (Figure 1B) . Similarly immunohistochemistry detected high levels of 2SC in an FH-mutant (HLRCC) type 2 PRCC though was absent in the stromal tissue ( Figure 1C ) and sporadic type 2 PRCC (data not shown and as previously described [11] ). We therefore performed a proteomic screen to identify succinated proteins in the cell lines and HLRCC tumour described above. 
Multiple Proteins Are Succinated in FH-Mutant Cells and Tumours
As previously reported, 2SC modification is very specific to cells with elevated fumarate [11, 21, 22] and we did not detect this modification in FH wildtype RPTC cells or tumour stromal tissue cells by immunoblotting and immunohistochemistry respectively (Figure 1 ). However, in the two HLRCC-derived cell lines and tumour, succinated peptides (as determined by a 116 Da mass shift [11] ) were detected in 60 different proteins (Table 1) . Furthermore, 10 of these proteins were succinated on cysteine residues with potentially regulatory functions ( Table 1 ; red font). 2SC targets identified an HLRCC tumour and tumour-derived cell lines. Succinated proteins are listed alphabetically by gene symbol, with succinated cysteine residues indicated. Targets highlighted in red indicate cysteine residues with either predicted or experimentally proven roles in protein function [23] . T = HLRCC tumour, U = UOK262 cell line, N = NCC-FH-1 cell line.
Succination Preferentially Targets Proteins Involved in Redox Regulation
Hierarchical clustering and gene ontology analyses suggest that most of the succination targets identified are involved in redox homeostasis or subject to ROS regulation (Table 2 ). This is unsurprising considering the critical roles of cysteine residues in cellular oxidative stress regulation (reviewed in [24] ). Previous studies have demonstrated the functional consequences of protein succination, including inhibition of the metabolic enzymes GAPDH and ACO2 [15, 16] , loss of KEAP1 function resulting in constitutive NRF2 expression in type 2 papillary RCC (PRCC) and Fh1-deficient mice [25, 26] and modification of reduced glutathione (GSH) in FH-deficient cells resulting in the amplification of ROS-dependent signaling [14] . In this study, we identified succination of Cys-106 at the active site of Parkinson disease protein 7 (PARK7) (also known as protein DJ-1) (Figure 2 ), a redox-sensitive protein that is implicated in cellular protection against oxidative stress in Parkinson's disease (reviewed in [27] ), mediates cellular responses to hypoxia [28] and can regulate metabolic pathways in RCC [29] . Interestingly PARK7 is closely associated with NRF2 through interaction with Superoxide dismutase 1 (SOD1) [30] (Figure 3) . Further, NRF2 and PARK7 are prognostic factors in lung cancer and upregulated in inflammatory multiple sclerosis lesions [31, 32] . Other succinated cysteine residues that may be critical to protein functions (highlighted in red font in Table 1 ) include Cys-299 of Aldose reductase (AKR1B1), which catalyzes the NADPH-dependent reduction of a wide variety of carbonyl-containing compounds to their corresponding alcohols with a broad range of catalytic efficiencies. Evidence suggests that Cys-299 may regulate the kinetic and inhibition properties of AKR1B1, but does not participate in catalysis [33] . Peroxiredoxins are antioxidant enzymes that control cytokine-induced peroxide levels and thereby mediate signal transduction in mammalian cells [34] . We observed succination of peroxiredoxin 1 and 3 (PRDX1 and PRDX3) at Cys-173 and Cys-108, respectively, both of which participate in intermolecular disulfide formation and are crucial to their molecular function [34, 35] . Succination was also detected in thioredoxin at a crucial residue Cys-73, which acts as a donor for nitrosylation of target proteins and therefore its succination may potentially impair the S-nitrosylating activity of thioredoxin [36] . Isoform 1 of Cytosolic Fe-S cluster assembly factor Nucleotide binding protein 1 (NUBP1) is succinated at residues Cys-22 and Cys-25, both of which are involved in iron-sulfur cluster (4Fe-4S) assembly [37] . Succination of NUBP1 may lead to enzymatic inhibition, similar to that observed in ACO2 [15] . Further, microsomal glutathione S-transferase 3 (MGST3) is succinated at Cys-150 and Cys-151, both of which are also targets of S-palmitoylation [38] . Site-directed mutagenesis of cysteines for some of the above proteins provides experimental evidence for their functional roles (Table 3) . Therefore modification by succination may be predicted to cause either a loss or gain of function in these proteins.
Experimental Section
Cell Lines and Human Tissue Samples
Cell lines were cultured as previously described [39] . The UOK262 cell line was a kind gift from Dr Marston Linehan [17] , and the NCC-FH-1 cell line from Professor Bin Teh (characterized by Choon Kiat Ong, Min Han Tan, Bernice Wong and Victoria Perrier-Trudova). The RPTC cell line was a kind gift from Professors Albert Ong and Lorraine Racusen. Anonymized human tumour and normal samples were collected with full ethical approval (MREC 05/Q1605/66) as approved by the Oxford Centre for Histopathology Research. Functional classification of succinated proteins using DAVID Bioinformatics Resources [40] [41] [42] ranked by statistical significance. Proteins were classified using the gene ontology functional annotation for biological processes (GOTERM_BP) and molecular function (GOTERM_MF). p-values < 0.001 were considered to be highly significant.
Proteomics and Mass Spectrometry
Tumour and normal kidney tissue and cells were homogenized and sonicated in Urea-SDS buffer and protein extracts separated by SDS-PAGE and processed for trypsin digestion and MS/MS analyses as previously described [15] . Database searches were performed against UniProt/SwissProt [23] or International Protein Index [43] database using Mascot [44] or CPFP 1.3.0 [45] . For label-free quantitation of succinated peptides, samples were analyzed in three technical replicates.
Immunohistochemistry (IHC) and Immunoblotting (IB)
Analyses of tumours and cell lines by IHC and IB were performed as previously described [11, 46] . The 2SC antibody was a kind gift from Dr Norma Frizzell, the fumarase antibody from Nordic Labs (Copenhagen, Denmark), and the β-actin antibody purchased from Abcam (Cambridge, UK). 
Gene Ontology Analysis
Functional classification of succinated proteins was performed using DAVID Bioinformatics Resources v6.7 (National Institute of Allergy and Infectious Diseases (NIAID), NIH, Frederick, MD, USA) [41, 42] . Protein network analysis for PARK7 was generated using STRING v9.1 [47, 48] . Table 3 . Mutational studies on cysteine residues observed to be succinated in FH-mutant tumours and cancer cells. [ 36, 56, 57] P09936 UCHL1 C90 C → S: Abolishes enzymatic activity. [58] [59] [60] Site-directed mutagenesis of cysteine residues that are targeted for succination, has provided evidence of their functional roles, which may be affected by succination.
Conclusions
Recent technological advances in mass spectrometry have facilitated high throughput screening of post-translational modifications in proteins. Here, we analysed cell lines and a tumour derived from HLRCC patients to try to identify the scope of the succinated proteome under FH-deficient settings. Succination of cysteine residues is a candidate mechanism for FH-associated oncogenesis, which is corroborated by genetic and biochemical evidence generated from the analyses of Fh1 knockout mice and gene expression profiling and exome sequencing of type 2 RCC [25, 26, 61] . Interestingly, some peptides were detected in only one or two of the three FH-mutant samples. However, this is most probably due to the heterogeneity of RCC [62, 63] ; both the UOK262 and NCC-FH-1 cell lines were generated from RCC metastases from different patients ( [17] and personal communication with Dr Teh). Furthermore, due to lack of antibody-based enrichment technologies, the "succinome" thus identified is biased towards abundant proteins in a cell line specific manner. Therefore we cannot rule out the possibility that the same succinated proteins were present in all samples, albeit at different levels, some below the threshold of detection. Given that 2SC was originally identified in diabetic rats and induced as a marker of mitochondrial stress in adipocytes resulting from glucotoxicity [12, 16, 18, 64] , it is likely that succination resulting from elevated levels of intracellular fumarate targets proteins involved in a diverse range of cellular and biological processes, including microtubule dynamics [65] , the NRF2-mediated antioxidant response [24, 25] , altered metabolism [15, 16, 39] and as identified here, redox homeostasis. Further studies are required to test the functionality and biological consequences of these modifications.
